Dr. Jérôme Fayette, MD, PhD
Claim this profileCentre Léon Bérard
Studies Squamous Cell Carcinoma
Studies Cancer
2 reported clinical trials
3 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
p16 positive
p16 negative
2Cancer
Stage IV
Clinical Trials Jérôme Fayette, MD, PhD is currently running
More about Jérôme Fayette, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Jérôme Fayette, MD, PhD has experience with
- Cetuximab
- Monalizumab
- NBTXR3
Breakdown of trials Jérôme Fayette, MD, PhD has run
Squamous Cell Carcinoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jérôme Fayette, MD, PhD specialize in?
Jérôme Fayette, MD, PhD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are p16 positive.
Is Jérôme Fayette, MD, PhD currently recruiting for clinical trials?
Yes, Jérôme Fayette, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Jérôme Fayette, MD, PhD has studied deeply?
Yes, Jérôme Fayette, MD, PhD has studied treatments such as Cetuximab, Monalizumab, NBTXR3.
What is the best way to schedule an appointment with Jérôme Fayette, MD, PhD?
Apply for one of the trials that Jérôme Fayette, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.